Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 165 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

Primary Immune Thrombocytopenia, Warm Autoimmune Hemolytic Anemia Phase2 China
Czechia
Turkey (Türkiye)
United Kingdom
View all

A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer

Metastatic Prostate Cancer (mCRPC) Phase1 Japan

Ilaris NIS in Korea

Hereditary Periodic Fever Syndromes, Cryopyrin-associated Periodic Syndromes (CAPS), Colchicine Resistance Familial Mediterranean Fever (crFMF), TNF Receptor Associated Periodic Syndrome (TRAPS), Hyper-IgD Syndrome / Mevalonate Kinase Deficiency (HIDS/MKD), Systemic Juvenile Idiopathic Arthritis (sJIA) South Korea

Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia

Hidradenitis Suppurativa (HS) Saudi Arabia

Fabhalta Capsules Specified Drug-use Survey

C3 Glomerulopathy Japan

Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.

Breast Cancer United Kingdom

Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)

Primary Hypercholesterolemia or Mixed Dyslipidemia South Korea

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer Phase1, Phase2 Japan
Singapore
Taiwan
United States
View all

Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults

Cryptosporidiosis Phase2 United States

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Secondary Progressive Multiple Sclerosis (SPMS) Phase3 Australia
Canada
China
Colombia
India
Israel
Switzerland
United States
View all